Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis

NCT02652819 is registered in ClinicalTrials.gov with Kyntra Bio as lead sponsor.

NCT NCT02652819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02652819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis
Lead sponsor
Kyntra Bio
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
June 13, 2017
Enrollment
154 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

anemia